In several life-threatening diseases, the blood plasma becomes deficient in the essential proteins. The Blood Plasma protein enables the blood to perform several vital functions like clotting and also protect the body against diseases by providing it immunity.
Lack of essential proteins in the Blood Plasma implies reduced the ability of the blood plasma to perform its functions. The therapy for treating the plasma protein deficiency includes supplying the body with external proteins through the oral pathway or through injected pathways.
Several life-threatening diseases can make the body lose its ability to manufacture all the vital plasma proteins. Several medical conditions can result in severe bleeding. Due to protein deficiency or blood loss, the blood plasma is not able to perform several functions.
There are different types of plasma therapy depending upon the plasma function affected.
Plasma coagulation therapy improves blood clotting and is administered for bleeding disorders due to trauma, liver disease, hemophilia A and B and Von Willebrand disease.
Plasma immunoglobulins therapy is administered to increase the ability of blood to neutralize foreign particles like bacteria and virus. Immunoglobulins therapy is used in the treatment of primary and secondary immunodeficiency diseases and autoimmune disorders and in CIDP and ITP.
Plasma hyperimmune therapy is administered for increasing the ability of the blood plasma to prevent and treat certain infections and diseases caused by them including Rabies, tetanus, hepatitis as well as in RH negative pregnancy and liver transplantation and surgeries.
Plasma Alpha-1 Proteinase therapy is administered for increasing the ability of the blood to protect tissues from the enzymes secreted by inflamed cells. Alpha-1 Proteinase therapy is used for the treatment of genetic disorder like Alpha-1 Antitrypsin deficiency which causes severe lung and liver diseases.
Plasma Albumin therapy is administered during cardiac surgery and for treatment of liver diseases and infections of severe nature. Albumin therapy is an emergency and surgical therapy and is also used for treating shocks and severe burns.
Plasma C1 esterase therapy is applied for treating a rare heredity condition called heredity angioedema. C1 esterase therapy increases the blood’s ability to control protein C1 found in the blood thus reducing life-threatening edema attacks.
The Plasma Protein Treatment market is showing a growing trend which is being attributed to both the supply and demand side of the market.
On the supply side Plasma protein extraction technology has now become simpler and less expensive hence there is more supply or availability of proteins derived from blood plasma. Also, more and more people are donating blood from which therapists are deriving plasma proteins. Safety and convenience are encouraging more and more people to donate their blood for therapeutic purposes. Doctors can prescribe a particular therapy when they are sure of its adequate supply, and hence the supply further generates the demand.
On the demand side, the incidence of life-threatening diseases are on the rise. But the good news is that through plasma therapy people with blood plasma deficiencies are now getting replenished by external protein supply derived from the blood of the donors. Earlier when protein therapy was scarce, affected patients would have to suffer due to the deficiency and could not live long. Availability of protein therapy derived from plasma is enabling the affected patients to recover from the deficiency. The deficient plasma supplied with external proteins is able to perform the vital body functions important for survival.
The Global Plasma Protein Treatment market is growing at the rate of 8.97 % CAGR. In 2016 the worth of the world plasma protein therapy market was 20,157.1 million USD. By 2021 the market is expected to cross 33,612.4 million USD. The growth is being evinced in the developed as well as the developing regions of the world. The developed regions are realizing supply-driven growth due to advancement in technology and discovery of newer applications of plasma therapy.
The post Plasma Protein Therapy for Life-Threatening Diseases appeared first on Research Reports Web.